Advanced Biomed (ADVB) Total Non-Current Liabilities (2024 - 2026)

Advanced Biomed has disclosed Total Non-Current Liabilities across 3 years of filings, most recently posting $10903.0 for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $10903.0, down 75.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $10903.0 (down 75.48% YoY), and the FY2025 annual result was $145651.0, up 125.71% from the prior year.
• Total Non-Current Liabilities came in at $10903.0 for Q1 2026 at Advanced Biomed, down from $115496.0 in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $193894.0 in Q3 2025 to a low of $10903.0 in Q1 2026.
• The 3-year median for Total Non-Current Liabilities is $64529.0 (2024), against an average of $90181.6.
• Across the five-year window, Total Non-Current Liabilities surged 125.71% in 2025 and plunged 75.48% in 2026, its largest moves.
• Advanced Biomed's Total Non-Current Liabilities stood at $56326.0 in 2024, then soared by 105.05% to $115496.0 in 2025, then sank by 90.56% to $10903.0 in 2026.
• The last three Total Non-Current Liabilities figures came in at $10903.0 (Q1 2026), $115496.0 (Q4 2025), and $193894.0 (Q3 2025), per Business Quant data.